LINDSEY BURGESS: Open Payments
NPI 1801437710 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 17 payments from 7 companies in 2025. Trend: 2023 $324 · 2024 $738 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $212 |
| Calliditas Therapeutics US Inc. | 3 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
Products named: Fabhalta, TARPEYO, Kerendia, JARDIANCE, JYNARQUE, FARXIGA, TERLIVAZ.
Industry payments across AL — which companies pay providers there.
